Does DAROLUTAMIDE Cause Urinary tract infection? 34 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Urinary tract infection have been filed in association with DAROLUTAMIDE (NUBEQA). This represents 1.1% of all adverse event reports for DAROLUTAMIDE.
34
Reports of Urinary tract infection with DAROLUTAMIDE
1.1%
of all DAROLUTAMIDE reports
4
Deaths
25
Hospitalizations
How Dangerous Is Urinary tract infection From DAROLUTAMIDE?
Of the 34 reports, 4 (11.8%) resulted in death, 25 (73.5%) required hospitalization, and 1 (2.9%) were considered life-threatening.
Is Urinary tract infection Listed in the Official Label?
Yes, Urinary tract infection is listed as a known adverse reaction in the official FDA drug label for DAROLUTAMIDE.
What Other Side Effects Does DAROLUTAMIDE Cause?
Fatigue (384)
Death (361)
Hot flush (203)
Asthenia (173)
Prostatic specific antigen increased (156)
Off label use (133)
Neuropathy peripheral (127)
Diarrhoea (122)
Dizziness (122)
Rash (116)
What Other Drugs Cause Urinary tract infection?
ADALIMUMAB (6,375)
LENALIDOMIDE (4,247)
ETANERCEPT (3,915)
OCRELIZUMAB (3,618)
TOFACITINIB (3,179)
METHOTREXATE (2,960)
DALFAMPRIDINE (2,757)
RITUXIMAB (2,579)
CARBIDOPA\LEVODOPA (2,151)
ABATACEPT (2,110)
Which DAROLUTAMIDE Alternatives Have Lower Urinary tract infection Risk?
DAROLUTAMIDE vs DARUNAVIR
DAROLUTAMIDE vs DARUNAVIR ETHANOLATE
DAROLUTAMIDE vs DARUNAVIR\RITONAVIR
DAROLUTAMIDE vs DASABUVIR
DAROLUTAMIDE vs DASABUVIR\OMBITASVIR HEMINONAHYDRATE\PARITAPREVIR\RITONAVIR